The Use of Alpha 1 Thymosin as an Immunomodulator of the Response Against SARS-Cov2

Investigators studied the effect of human Thymosin-alpha-1 treatment on the immune system in population groups with different thymic function levels in the scenario of SARS-CoV2 infection.